Combined hormone therapy risks continue

Study: A followup of the participants in the Women's Health Initiative (WHI) clinical trial has found that the women who were taking combined hormone therapy appear to have a higher cancer risk than women in the placebo group three years after the study was halted.

Please complete all fields marked below with * .
*Issue:
*Your Name:
*E-mail:
Phone:

Thank you for taking time to write. Please provide enough information for us to find and address your concern. If reporting a typo, please include the misspelled word. If you are reporting a mistake in the newspaper, please include the headline and page number:

*Details:
Thank you for writing us. We will try to address every report sent to thestar.com and regret we can not respond to submissions in person. Personal information requested above is for verification process only and won't appear on thestar.com without your consent. Read our privacy policy.